
"Sector" = median of Healthcare across 84 companies
IDEXX Laboratories, Inc. is a global leader in veterinary diagnostics, providing a comprehensive range of testing products and services for companion animals (dogs, cats, horses) and livestock. The company develops, manufactures, and distributes diagnostic instruments, consumables, reference laboratory services, and practice management software. Its flagship products include the IDEXX SNAP rapid tests, Catalyst chemistry analyzers, and the Cornerstone practice management system. IDEXX also offers water quality testing solutions for environmental and food safety applications.
IDEXX generates revenue primarily through three segments: Companion Animal Group (CAG), Water Quality, and Livestock, Poultry & Dairy. The CAG segment accounts for over 85% of total revenue, driven by recurring sales of consumables and reference laboratory services. The company's razor-blade model—selling analyzers at low margins and profiting from high-margin consumables—ensures sticky customer relationships. Revenue is largely subscription-like, with over 90% of CAG revenue recurring. Water quality testing provides a smaller but stable revenue stream.
IDEXX operates in the healthcare sector, specifically the diagnostics and research industry. It is the dominant player in the veterinary diagnostics market, with an estimated 30-35% global share. Competitors include Zoetis, Heska (now part of Mars), and Antech Diagnostics. IDEXX's competitive advantages include its extensive installed base of analyzers, proprietary test menu, and integrated software ecosystem. High switching costs for veterinary clinics and continuous innovation in point-of-care testing reinforce its market position.
IDEXX's primary customers are veterinary clinics and hospitals, ranging from small independent practices to large corporate chains. The company also serves reference laboratories, animal hospitals, and water testing facilities. Geographically, the US is the largest market, contributing about 70% of revenue, with international markets (Europe, Asia-Pacific, Latin America) accounting for the remainder. The company's products are used by veterinarians worldwide, and it has a direct sales force in over 30 countries.
An auto-generated descriptive profile based on company data, for informational purposes only.
No 24-hour summary has been generated yet.
Latest saved period: March 2026 · 2026-03-31
Cash dividends by ex-date, not an investment recommendation.
Wrqti brings IDEXX Laboratories, Inc. data into one page covering available price, financial statements, valuation ratios, margins, cash-flow metrics, news, and alerts. This page helps you understand the numbers and is not a buy or sell recommendation.
Companies in the Healthcare sector you can compare with IDEXX Laboratories, Inc.:
When available, the page shows quarterly and annual statements plus ratios such as PE, price to book, profit margin, and free cash flow. Latest financial period shown: March 2026.
Wrqti content depends on available data and third-party sources and may include delays or errors. Review official company filings and consult a licensed financial advisor before making investment decisions. Read the data methodology.